Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing.
about
Examining the impact of reimbursement on referral to bone density testing for older adults: 8 years of data from the Barwon Statistical Division, Australia.Predictors of locating women six to eight years after contact: internet resources at recruitment may help to improve response rates in longitudinal research.Measuring patient perceptions about osteoporosis pharmacotherapy.Osteoporosis quality indicators using healthcare utilization data.High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in Pennsylvania.Osteoporosis management and the utilization of FRAX®: a survey amongst health care professionals of the Asia-Pacific.Bone density, health beliefs, and osteoporosis preventing behaviors in menOsteoporosis management and fractures in the Métis of Ontario, Canada.Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.Digital X-ray radiogrammetry of hand or wrist radiographs can predict hip fracture risk--a study in 5,420 women and 2,837 men.Longitudinal trends in use of bone mass measurement among older americans, 1999-2005.Patient and physician predictors of post-fracture osteoporosis management.Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA resultsThe geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United StatesOsteoporosis onset differences between rural and metropolitan populations: correlation to fracture type, severity, and treatment efficacy.Patient perceptions of the path to osteoporosis care following a fragility fracture.Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials.The post-fracture care gap among Canadian First Nations peoples: a retrospective cohort study.Hip fracture and other predictors of anti-osteoporosis drug use in Norway.Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy's fracture clinic screening program.The effect modification of supplemental insurance on the relationship between race and bone mineral density screening in female Medicare beneficiaries.The burden of hip fractures - why aren't we better at prevention?
P2860
Q30670414-19E44B84-EC1E-4F1C-8F90-62619C872661Q33288109-391DE9C5-6273-4513-B749-9B1972CC90A6Q33482035-27226642-64FD-430D-8FC4-E211F2115187Q33616400-FEAFAAF4-A0DF-4053-B923-3A790930B44DQ33913990-261176DB-81EC-4AFA-82EB-26B3284C8860Q34504693-1914C131-4FD6-4049-8AFF-3DCFC8110125Q35137008-9F004D2E-0306-41AD-9989-990406B51E5DQ35547167-42EC1C77-E288-4123-A3A3-586C8ECAF1AFQ35774970-BDF4EC3C-A371-4C5A-8FA3-18A1E8697DF3Q36756129-85AA0453-A839-41BD-B74F-8BB95D3350CBQ36813581-B8F83806-5EDA-43E0-AC2E-98D15A71F587Q36841097-29B5895B-DA29-43B9-B048-2B5CF9BA8B1DQ37306068-37153601-DDE6-42AD-9C85-3C068399386EQ37310102-19F2918B-0185-4570-BAEC-37212C03B11CQ39986824-84E2BC5E-9246-4D8C-8951-5CB24D8A994BQ40059033-300A40FE-C065-4064-AB60-9E8A5C948780Q41162232-B4DF364A-D968-48E1-8959-06951D55B81EQ44485333-2FB2D07F-175F-400C-A827-56929E5A1DC3Q44656061-E0A394C3-AEDF-472C-956B-D5567EFD2367Q44820522-E627120E-FF9A-4007-AEB7-9E7B7AA06DD3Q45729788-0E51359C-3D54-4B28-897F-3AA45D748048Q47851120-2D97D7A2-2866-437A-811F-875E9F5F843AQ49808666-AEF0D349-D2C7-48E3-A09A-051DC960DEB4
P2860
Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Access to osteoporosis treatme ...... x-ray absorptiometry testing.
@en
Access to osteoporosis treatme ...... x-ray absorptiometry testing.
@nl
type
label
Access to osteoporosis treatme ...... x-ray absorptiometry testing.
@en
Access to osteoporosis treatme ...... x-ray absorptiometry testing.
@nl
prefLabel
Access to osteoporosis treatme ...... x-ray absorptiometry testing.
@en
Access to osteoporosis treatme ...... x-ray absorptiometry testing.
@nl
P2093
P1433
P1476
Access to osteoporosis treatme ...... y x-ray absorptiometry testing
@en
P2093
Dorcas E Beaton
Gillian A Hawker
Monique A M Gignac
Suzanne M Cadarette
P304
P356
10.1097/MLR.0B013E318054689F
P50
P577
2007-09-01T00:00:00Z